Repo Dosen ULM
KOR - 2023 - Survival of Lung Adenocarcinoma Patients with Tyrosine Kinase Inhibitor Therapy Based on EGFR Mutation Status in Tumor and Plasma Samples
JavaScript is disabled for your browser. Some features of this site may not work without it.
| dc.contributor.author | Oktaviyanti, Ika Kustiyah | |
| dc.date.accessioned | 2024-06-21T07:47:29Z | |
| dc.date.available | 2024-06-21T07:47:29Z | |
| dc.date.issued | 2023 | |
| dc.identifier.uri | https://repo-dosen.ulm.ac.id//handle/123456789/35125 | |
| dc.subject | Kedokteran | en_US |
| dc.title | KOR - 2023 - Survival of Lung Adenocarcinoma Patients with Tyrosine Kinase Inhibitor Therapy Based on EGFR Mutation Status in Tumor and Plasma Samples | en_US |
| dc.type | Other | en_US |
Files in this item
This item appears in the following Collection(s)
-
Turnitin / Peer Review / Koran / Hak Cipta / Hak Paten / Penelitian / Pengabdian [17359]
Repositori untuk bidang Turnitin / Peer Review / Koran / Hak Cipta / Hak Paten / Penelitian / Pengabdian